10Nov
10Nov
OmniLife and ACTION Network Solidify Collaboration to Drive Innovation
OmniLife, a health technology communication and collaboration platform, has finalized its formal collaboration with the Advanced Cardiac Therapies Improving Outcomes Network, or ACTION. The organizations will work together to drive innovation around patient care and clinical decision making, specifically with the goal of improving outcomes for children with heart failure. Read more >>
09Nov
EY Announces 27 Women Founders Selected for the EY Entrepreneurial Winning Women™ North America Class of 2021
EY announces the 27 women founders selected for the EY Entrepreneurial Winning Women™ North America Class of 2021. The program, now in its 14th year, identifies ambitious women entrepreneurs who are leading thriving organizations and provides them with the access, advisors and resources needed to scale their companies to their full potential as market-leading innovators. Program engagement offers participants executive education and introductions to the vast EY global entrepreneurial ecosystem as well as the Entrepreneurial Winning Women community worldwide. Teresa...
08Nov
Elizabeth Banks On Controlling Her Own Destiny In Hollywood
In this week’s Sunday Sitdown, three-time Emmy-nominated actor Elizabeth Banks talks to Willie Geist about making a career out of her own opportunities. As a true “boss mom,” Banks started her own production company, launched a new podcast and is now entering the wine business.
05Nov
CT Lab Hopes to Decrease Dangers of Ingested Button Batteries
Inside thermometers or even your key fob, batteries power up a lot of our everyday lives. The Poison Control says more than 3,500 people in the United States swallow button batteries every year which can cause disastrous, even deadly, outcomes. “This should not be a problem. Children should not be passing away or harmed from ingesting batteries,” said Melissa Fensterstock, the co-founder and CEO of Landsdowne Labs, which rents space on Fairfield University’s campus. Scientists in that Connecticut lab are...
05Nov
India to Start Clinical Trials of US-Based Second Generation, Low-Cost Covid-19 Vaccine
India will soon start clinical trials of US-based Akston Biosciences second-generation Covid-19 vaccine — one of the most promising candidates that can be rapidly produced at a low cost, suitable for repeated dosing if immunity wanes and requires no refrigeration. The vaccine samples have been sent to the Central Drugs Laboratory in Kasauli as a protocol for checking the safety prior to starting its use in clinical trials. Read more >>
04Nov
PlateletBio Completes $75.5M Series B Financing
PlateletBio, a preclinical-stage biotechnology company pioneering an entirely new platform of allogeneic cell therapies based on platelet biology, today announced that it has raised $75.5 million in Series B financing. The round includes new investors SymBiosis, K2 HealthVentures and Oxford Finance as well as participation from existing investors Ziff Capital Partners and Qiming Venture Partners. Read more >>
03Nov
ESPN Events’ Fenway Bowl Announces Wasabi Technologies as Title Sponsor
The Fenway Bowl, an annual college football bowl game at Fenway Park, has announced Boston-based Wasabi Technologies, the premier provider of hot cloud storage solutions for business, as the title sponsor as part of a new multi-year agreement. The Wasabi Fenway Bowl has also announced the formation of an Executive Committee, a 16-member organization that will provide strategic recommendations to foster the game’s educational and community-oriented mission. Read more >>
03Nov
OmniLife Joins Forces with ATP-Bio To Advance Software
OmniLife, a health technology communication and collaboration platform, has launched an affiliation with ATP-Bio as an official ATP-Bio member to work together to advance its software into the organ, tissue, cell preservation and regenerative medicine industries. OmniLife’s groundbreaking technology platform is designed to improve communication between all key stakeholders in the organ and tissue donation, transplantation, and research industries. Read more >>
03Nov